Schroeckenfuchs has been working with Novartis for almost 22 years. In his current role, he oversees a team of over 450 people. In March 2022, it partnered with Pharmax Pharmaceuticals to enhance access to treatment for cardiovascular disease and Type 2 diabetes in the U.A.E. In June 2023, Novartis also partnered with the Emirates Dermatology Society to raise awareness of skin diseases.